In vitro hemocompatibility evaluation of poly (4-hydroxybutyrate) scaffold

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 5, 2014, Pages 1233-1243

  Liu, Yunqi ^a   Cai, Dongmei ^a   Yang, Jing ^a   Wang, Yujie ^b   Zhang, Xi ^a   Yin, Shengli ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Biomaterial; Hemocompatibility; Poly 4 hydroxybutyrate; Scaffold; Tissue engineering

Indexed keywords

ALBUMIN; FIBRIN; GLOBULIN; HYDROXYBUTYRIC ACID; POLY 4 HYDROXYBUTYRIC ACID; POLYVINYLCHLORIDE; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING TEST; CONTROLLED STUDY; DIAGNOSTIC TEST; ERYTHROCYTE; ERYTHROCYTE HEMOLYSIS TEST; HEMOCOMPATIBILITY; HUMAN; IN VITRO STUDY; LEUKOCYTE; NEUTROPHIL; PHYSICAL CHEMISTRY; PLATELET ADHESION TEST; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE;

EID: 84902169120     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Ma PX. Biomimetic materials for tissue engineering. Adv Drug Deliv Rev 2008; 60: 184-198.
2. L'Heureux N, Dusserre N, Konig G, Victor B, Keire P, Wight TN, Chronos NA, Kyles AE, Gregory CR, Hoyt G, Robbins RC and McAllister TN. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006; 12: 361-365.
3. Andrée B, Bär A, Haverich A and Hilfiker A. Small intestinal submucosa segments as matrix for tissue engineering: review. Tissue Eng Part B Rev 2013; 19: 279-291.
4. Mendelson K and Schoen FJ. Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng 2006; 34: 1799-1819.
5. Stock UA and Mayer JE Jr. Tissue engineering of cardiac valves on the basis of PGA/PLA Co-polymers. J Long Term Eff Med Implants 2001; 11: 249-260.
6. Deeken CR and Matthews BD. Characterization of the Mechanical Strength, Resorption Properties, and Histologic Characteristics of a Fully Absorbable Material (Poly-4-hydroxybutyrate-PHASIX Mesh) in a Porcine Model of Hernia Repair. ISRN Surg 2013; 2013: 238067.
7. McGann CL, Levenson EA and Kiick KL. Resilin-Based Hybrid Hydrogels for Cardiovascular Tissue Engineering. Macromolecules 2013; 214: 203-213.
8. Somers P, Cuvelier CA, Somer FD, Cornelissen M, Cox E, Verloo M, Chiers K and van Nooten G. Gamma radiation alters the ultrastructure in tissue-engineered heart valve scaffolds. Tissue Eng Part A 2009; 15: 3597-604.
9. Knight RL, Wilcox HE, Korossis SA, Fisher J and Ingham E. The use of acellular matrices for the tissue engineering of cardiac valves. Proc Inst Mech Eng H 2008; 222: 129-143.
10. Ratner BD. The catastrophe revisited: blood compatibility in the 21st Century. Biomaterials 2007; 28: 5144-5147.
11. EN ISO 10993-4:2009. Biological evaluation of medical devices-Part 4: Selection of tests for interactions with blood (ISO 10993-4:2002, including Amd 1:2006).
12. Hanson SR and Ratner BD. Evaluation of blood-materials interactions. Biomaterials Science. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, eds. An Introduction to Materials in Medicine. San Diego, 2004. pp: 367-378
13. Hein S, Söhling B, Gottschalk G and Steinbüchel A. Biosynthesis of poly(4-hydroxybutyric acid) by recombinant strains of Escherichia coli. FEMS Microbiol Lett 1997; 153: 411-418.
14. Williams SF, Rizk S and Martin DP. Poly-4-hydroxybutyrate (P4HB): a new generation of resorbable medical devices for tissue repair and regeneration. Biomed Tech (Berl) 2013; 58: 439-452.
15. Bünger CM, Grabow N, Sternberg K, Goosmann M, Schmitz KP, Kreutzer HJ, Ince H, Kische S, Nienaber CA, Martin DP, Williams SF, Klar E and Schareck W. A biodegradable stent based on poly(L-lactide) and poly(4-hydroxybutyrate) for peripheral vascular application: preliminary experience in the pig. J Endovasc Ther 2007; 14: 725-733.
16. Chen X, Yang X, Pan J, Wang L and Xu K. Degradation behaviors of bioabsorbable P3/4HB monofilament suture in vitro and in vivo. J Biomed Mater Res B Appl Biomater 2010; 92: 447-455.
17. Chen GQ and Wu Q. The application of polyhydroxyalkanoates as tissue engineering materials. Biomaterials 2005; 26: 6565-6578.
18. Sevastianov VI, Perova NV, Shishatskaya EI, Kalacheva GS and Volova TG. Production of purified polyhydroxyalkanoates (PHAs) for applications in contact with blood. J Biomater Sci Polym Ed 2003; 14: 1029-1042.
19. Gao W, Lin T, Li T, Yu M, Hu X and Duan D. Sodium alginate/heparin composites on PVC surfaces inhibit the thrombosis and platelet adhesion: applications in cardiac surgery. Int J Clin Exp Med 2013; 6: 259-268.
20. Nair CS, Vidya R and Ashalatha PM. Hexamoll DINCH plasticised PVC containers for the storage of platelets. Asian J Transfus Sci 2011; 5: 18-22.
21. Gao Y, Chen L, Zhang Z, Gu W and Li Y. Linear Cationic Click Polymer for Gene Delivery: Synthesis, Biocompatibility, and In Vitro Transfection. Biomacromolecules 2010; 11: 3102-3111.
22. Li L, Tu M, Mou S and Zhou C. Preparation and blood compatibility of polysiloxane/liquid-crystal composite membranes. Biomaterials 2001; 22: 2595-2599.
23. Document ASTM. Standard practice for assessment of hemolytic properties of materials designation: F 756-00. Annu Book ASTM Stand 2005; 309-13.
24. Liu Y, Yin S, Wang Y, Cai D, Zhang X and Zhang W. Effect of high porosity on biodegradation of poly (4-hydroxybutyrate) in vivo. J Biomater Appl 2014; 28: 1105-1112.
25. Pan J, Li G, Chen Z, Chen X, Zhu W and Xu K. Alternative block polyurethanes based on poly (3-hydroxybutyrate-co-4-hydroxybutyrate) and poly (ethylene glycol). Biomaterials 2009; 30: 2975-2984.
26. Kirkizlar O, Kendir M, Karaali Z, Ure U, Ozbay G, Selcuk D and Kazancioglu R. Acute renal failure in a patient with severe hemolysis. Int Urol Nephrol 2007; 39: 651-654.
27. Xu JL, Zhong ZC, Yu DZ, Liu F and Luo JM. Effect of micro-arc oxidation surface modification on the properties of the NiTi shape memory alloy. J Mater Sci Mater Med 2012; 23: 2839-2846.
28. Cool DE, Edgell CJ, Louie GV, Zoller MJ, Brayer GD and MacGillivray RT. Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of beta-factor XIIa. J Biol Chem 1985; 260: 13666-136676.
29. Favaloro EJ, Lippi G and Koutts J. Laboratory testing of anticoagulants: the present and the future. Pathology 2011; 43: 682-692.
30. Zorio E, Gilabert-Estellés J, España F, Ramón LA, Cosín R and Estellés A. Fibrinolysis: the key to new pathogenetic mechanisms. Curr Med Chem 2008; 15: 923-929.
31. Kim IC, Choi JG and Tak TM. Sulfonated polyether-sulfone by heterogeneous method and its membrane performances. J Appl Polym Sci 1999; 74: 2046-2055.
32. Chandra PS and Michael S. Blood compatible materials and devices. Pennsylvania (USA): Technomic Publishing Company; 1991. pp: 136.
33. Anderson JM and McNally AK. Biocompatibility of implants: lymphocyte/macrophage interactions. Semin Immunopathol 2011; 33: 221-233.
34. Chanard J, Thomas M and Rieu P. Membrane roughness: A relevant concept in haemodialysis. Nephrol Ther 2010; 6: 158-161.
35. Kanezaki S, Kawakami H, Nagaoka S and Kubota S. Biocompatibility of fl uorinated po-ly(organophosphazene). J Biomater Sci Polym Ed 2003; 14: 469-479.
36. Yamazoe H and Tanabe T. Drug-carrying albumin film for blood-contacting biomaterials. J Biomater Sci Polym Ed 2010; 21: 647-657.
37. Sivaraman B and Latour RA. The adherence of platelets to adsorbed albumin by receptor-mediated recognition of binding sites exposed by adsorption-induced unfolding. Biomaterials 2010; 31: 1036-1044.
38. Stamm C, Khosravi A, Grabow N, Schmohl K, Treckmann N, Drechsel A, Nan M, Schmitz KP, Haubold A and Steinhoff G. Biomatrix/polymer composite material for heart valve tissue engineering. Ann Thorac Surg 2004; 78: 2084-2092.
39. Chen Z, Cheng S, Li Z, Xu K and Chen GQ. Synthesis, characterization and cell compatibility of novel poly(ester urethane)s based on poly(3-hydroxybutyrate-co-4-hydroxybutyrate) and poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) prepared by melting polymerization. J Biomater Sci Polym Ed 2009; 20: 1451-1471.